Psychiatry · Substance Use Disorders (Alcohol, Opioids, Other Substances)

A 28-year-old woman with severe alcohol use disorder and decompensated cirrhosis (Child-Pugh class C) requires pharmacotherapy for relapse prevention. Which agent is preferred in this patient?

  • A Disulfiram
  • B Acamprosate
  • C Naltrexone
  • D Topiramate
Correct answer: B. Acamprosate

Explanation

Acamprosate is renally excreted and is the preferred agent in patients with severe hepatic impairment. Both naltrexone and disulfiram are hepatically metabolized and are contraindicated or require caution in severe liver disease. Naltrexone carries a warning for hepatotoxicity, and disulfiram is hepatically metabolized with its own risk of hepatotoxicity. Acamprosate has no hepatic metabolism.

Reference: Kaplan and Sadock's Comprehensive Textbook of Psychiatry, 10th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.

Sponsored

Want to test yourself?

Create a free account for timed mock tests, mistake tracking, and FSRS spaced-repetition revision across 43,000+ MCQs.

Start free → Log in

More Substance Use Disorders (Alcohol, Opioids, Other Substances) MCQs

See all Substance Use Disorders (Alcohol, Opioids, Other Substances) MCQs →